E D P Drug and Alcohol Services Revenue and Competitors

Exeter, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • E D P Drug and Alcohol Services's estimated annual revenue is currently $6.3M per year.(i)
  • E D P Drug and Alcohol Services's estimated revenue per employee is $90,000

Employee Data

  • E D P Drug and Alcohol Services has 70 Employees.(i)
  • E D P Drug and Alcohol Services grew their employee count by -10% last year.

E D P Drug and Alcohol Services's People

NameTitleEmail/Phone
1
Criminal Justice Community Transitions WorkerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M16828%N/AN/A
#2
$48.8M3906%N/AN/A
#3
$27.5M25010%N/AN/A
#4
$24.3M2219%N/AN/A
#5
$27.1M24624%N/AN/A
#6
$7.9M793%N/AN/A
#7
$8.1M813%N/AN/A
#8
$3M386%N/AN/A
#9
$3.9M49-8%N/AN/A
#10
$6.5M726%N/AN/A
Add Company

What Is E D P Drug and Alcohol Services?

EDP Drug & Alcohol Services (EDP) is a charity working primarily in the South West, providing services across Devon and Dorset, in the community and within prisons. We offer a number of dynamic and innovative initiatives which work alongside people to improve their wellbeing, social connections and employability. We are passionate about supporting individuals who face complex issues, including substance misuse, mental ill health, and other harmful, addictive and offending behaviour, to improve their lives. The fundamental belief underpinning our work is that, given the right support and resources, people can and do make remarkable changes.

keywords:N/A

N/A

Total Funding

70

Number of Employees

$6.3M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

E D P Drug and Alcohol Services News

2022-04-19 - Court orders Norfolk drugs dealer to pay back £4k

A drug dealer who made almost a quarter of a million pounds from his crimes has been ordered to pay back just £4,600.

2022-04-13 - Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated ...

... 16-fold of that of PBI-0451 and 7-fold of that of EDP-235. ASC11 is an in-house discovered oral small molecule drug candidate,...

2022-04-13 - Ascletis' oral drug shows potential for Covid-19 treatment

Ascletis Pharma has reported that its oral small molecule drug candidate ASC11 ... 16-fold and seven-fold to that of PBI-0451 and EDP-235,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A73813%N/A
#2
$9.9M73-3%N/A
#3
$10M746%N/A
#4
$17.7M78-4%N/A
#5
$19.4M88-7%N/A